We are live on ! Find out more
XYN

Xynomic Pharmaceuticals Holdings, Inc. Common Stock
XYN

Delisted

XYN was delisted on the 16th of July, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Xynomic Pharmaceuticals Holdings, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 0.07% → 0% (-0.07%)

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $107K → $0 (-$107K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$34K
2
BI
Bulldog Investors
New Jersey
-$34K
3
YCM
Yakira Capital Management
Connecticut
-$34K
4
UBS Group
UBS Group
Switzerland
-$5K

XYN Hedge Fund Activity: Q3 2019 in Review

0 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Xynomic Pharmaceuticals Holdings, Inc. Common Stock (XYN) for Q3 2019, worth a combined $0 — down 100% from $107K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of XYN and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was 683 Capital Management, exiting entirely with an estimated $34K sold.

  • 0 institutional investors held Xynomic Pharmaceuticals Holdings, Inc. Common Stock (XYN) as of Q3 2019, down from 4 in Q2 2019.
  • Funds reported $0 of Xynomic Pharmaceuticals Holdings, Inc. Common Stock stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Xynomic Pharmaceuticals Holdings, Inc. Common Stock positions in Q3 2019 and 4 closed out, a net change of -4 holders.
  • The largest Xynomic Pharmaceuticals Holdings, Inc. Common Stock seller in Q3 2019 was 683 Capital Management, an estimated $34K sold.

Based on aggregated 13F filings for Q3 2019.